PROVENGE, an autologous cellular immunotherapy used as a treatment for asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer (CRPC). Visit www.provengehcp.com
PROVENGE, an autologous cellular immunotherapy used as a treatment for asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer (CRPC). Visit www.provengehcp.com
Register for the PROVENGE Jumpstart Program. Find information and support in your battle against advanced prostate cancer, visit Provenge.com for more.
PROVENGE, an autologous cellular immunotherapy used as a treatment for asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer (CRPC). Visit www.provengehcp.com